Pathological and Clinical Aspects of COPD Flashcards
1
Q
What is the definition of COPD?
A
- Progressive airflow obstruction that is not fully reversible and does not change markedly over several months
2
Q
What are the common causes of COPD?
A
- Smoking
- Alpha 1 antitrypsin deficiency
3
Q
What is the pathogenesis of COPD?
A
- Loss of elasticity and alveolar attachements due to emphysema (airways collapse on expiration causing air trapping, hyperinflation, increased work of breathing and SOB)
- Goblet cell metaplasia with mucus plyggung of lumen
- Inflammation of the airway wall
- Thickening of bronchiolar wall (smooth muscle hypertrophy and peribronchial fibrosis)
4
Q
What is chronic bronchitis?
A
- Production of sputum on most days for at least 2 months in at least 2 years
- Larger airways >4mm in diameter
- Develop airway inflammation (predominantly neutrophilic with CD8 cytotoxic lymphocytes and some eosinophils which leads to scarring and thickening of the airways)
- Inflammatory mediators include TNF, IL-8, neutrophil elastase, proteinase 3, cathespin G, elastase and MMPs from macrophages and ROS
- Squamous metaplasia and as tissue is destroyed you lose the interstitial support of the tissue around the bronchioles making them more collapsible
5
Q
What is emphysema?
A
- Abnormal, permanent enlargement of the airspaces distal to the terminal bronchioles
- Four general types but centri-acinar (damage around respiratory bronchioles) and pan-acinar (uniformly enlarged from the level of terminal bronchiole distally) are most important
6
Q
What are the stages of COPD?
A
- 1) Mild - FEV1 80%
- 2) Moderate - FEV1 50-79%
- 3) Severe - FEV1 30-49%
- 4) Very severe - FEV1 <30% or <50% with respiratory failure
7
Q
What does type 1 respiratory failure look like?
A
- Pink puffer
- High respiratory drive
- ↓PaO2, ↓PaCO2
- Signs and symptoms include desaturation on exercise, pursed lip breathing, use of accessory muscles, wheeze, indrawing of intercostals and tachypnoea
8
Q
What does type 2 respiratory failure look like?
A
- Low respiratory drive
- Type 2 respiratory failure
- ↓PaO2, ↑PaCO2
- Signs and symptoms include cyanosis, warm peripheries, bounding pulse, flapping tremor, confusion, drowsiness, right heart failure, oedema and raised JVP
9
Q
What are the processes in asthmatic airway inflammation?
A
- CD4+ lymphocytes
- T lymphocytes
- Eosinophils
10
Q
What are the processes involved in COPD airway inflammation?
A
- CD8+
- T lymphocytes
- Macrophages
- Neutrophils
11
Q
Why does cigarette smoking cause COPD?
A
- Cigarette smoking leads to reduced cilial motility, neutrophilic inflammation, mucus hypertrophy and Goblet cells, increased protease activity against anti-protease inhibition leading to more damage to tissues in the lungs (i.e. α1 antitrypsin is one of the main anti-proteases) and oxidative stress. Furthermore it can lead to squamous metaplasia.
12
Q
Long term management of COPD
A
- Smoking cessation
- Pneumococcal and annual flu vaccine
- Step 1 - beta-2 agonists (i.e. salbutamol, terbutaline) or short acting antimuscarinics (i.e. ipratropium bromide)
- Step 2
- If no asthmatic or steroid responsive features then LABA (i.e. salmeterol) plus LAMA (i.e. tiotropium)
- If asthmatic or steroid responsive features then LABA (i.e. salmeterol) plus inhaled corticosteroid (i.e. (budenoside, fluticasone)
- Step 3 - Combination of LABA, LAMA and ICS
- Inhaled bronchodilators (salbutamol, salmeterol)
- In severe cases can use nebulisers, oral theophylline, oral mucolytics (i.e. carbocysteine), long-term prophylactic antibiotics (i.e. azithromycin) and LTOT
13
Q
Presentation of COPD
A
- Chronic SOB
- Sputum production
- Wheeze
- Recurrent respiratory infections
14
Q
Diagnosis of COPD
A
- FEV1/FVC ratio <0.7 (obstructive picture)
- No reversibility (as seen in asthma)
- CXR to rule out lung cancer
- FBC for polycythaemia or anaemia (raised Hb is sign of chronic hypoxia)
- Transfer factor for carbon monoxide/TLCO is decreased in COPD - can indicate severity of disease
15
Q
When LTOT is considered
A
- Chronic hypoxia
- Polycythaemia
- Cyanosis
- HF secondary to pulmonary HTN
NB - Can’t be used if patient is still smoking.